Latest filing published 09 Jun 2026 for Pulmonx Corp. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by Daniel P. Florin span 2 companies, the busiest being Pulmonx Corp and AtriCure, Inc. Over a trading history stretching from 20 May 2021 to 5 June 2026, the count stands at 11 filings.
On the open market, the record shows 3 purchases worth €229k and 1 sale worth €40k. The net balance comes to €189k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants.
Half of the purchases are above €82k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 9 June 2026, the filings show a share grant in Pulmonx Corp. The last purchase on record was published on 5 June 2025, which is 500 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations